Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $2.44M in the twelve months ending March 31, 2024, with 27.09% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $510.82K. In the year 2023, Xenetic Biosciences had annual revenue of $2.54M with 48.80% growth.

• Revenue (ttm): $2.44M
• Revenue Growth: +27.09%
• P/S Ratio: 2.62
• Revenue / Employee: $611,240
• Employees: 4
• Market Cap: 6.41M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.54M	833.06K	48.80%
Dec 31, 2022	1.71M	546.23K	47.06%
Dec 31, 2021	1.16M	723.75K	165.64%
Dec 31, 2020	436.94K	419.88K	2,460.31%
Dec 31, 2019	17.07K	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	7.59M	4.59M	152.83%
Dec 31, 2016	3.00M	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	1.00M	706.40K	240.60%
Dec 31, 2012	293.60K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.